Company news

CSL Limited news in 2016

CSL Limited's news releases, calls and decks from 2016, newest first.

View company

Positive Results from CSL112 Phase 2b Trial

November 15, 2016

Afstyla CHMP Recommendation

November 13, 2016

FDA Accepts BLA for Hereditary Angioedema Therapy

August 29, 2016

2016 FY Results Announcements and Analysts Briefing

August 16, 2016

AFSTYLA (rFVIII-Single Chain) FDA approval

May 25, 2016

Flucelvax Quadrivalent (Influenza Vaccine) - FDA Approval

May 23, 2016

IDELVION(R) (rFIX-FP) - European Commission Approval

May 11, 2016

CSL to acquire Novartis influenza vaccine business

March 30, 2016

Chairman`s Address to Shareholders

March 30, 2016

Recombinant Technologies

March 30, 2016

Chairmans and MDs address to shareholders

March 30, 2016

Announcement of buy-back

March 30, 2016

Appointment of Paul Perreault as Executive Director

March 30, 2016

New US$500 million Private Placement

March 30, 2016

Full Year Results, Appendix 4E and Analysts Presentation

March 30, 2016

CSL Settles US Class Action and Updated Profit Guidance

March 30, 2016

Half Yearly Report and Accounts

March 30, 2016

Appendix 4E, FY Results and Analysts Presentation

March 30, 2016

Changes relating to buy-back - Appendix 3D

March 22, 2016

IDELVION(R) (rFIX-FP) - FDA approval

March 6, 2016

IDELVION(R) (rFIX-FP) - CHMP recommendation

February 28, 2016

Half Year Accounts

February 15, 2016

Announcement of buy-back - Appendix 3C

February 11, 2016

US FDA Accepts for Review rFVIII BLA

February 10, 2016

Update on Novartis Influenza Vaccine Acquisition

February 10, 2016

Response to an ASX Query

February 10, 2016

Placement

February 10, 2016

New US Private Placement

February 10, 2016

Half Year Report and Accounts

February 10, 2016

FY2015 Results Announcement and Analysts Presentation

February 10, 2016

CSL Behring to Present Pivotal Data

February 10, 2016

CEO Succession

February 10, 2016

Appendix 4E Directors Report and Financial Statements

February 10, 2016

Appendix 4D, Half Year Results Release and Briefing

February 10, 2016

Decks in 2016